Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn

Burns

Volumn 35, Issue 1, 2009, Pages 75-79

  Yang, Rong hua ^a   Rong, Xin zhou ^a   Hua, Rong ^a   Zhang, Tao ^a  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Amikacin; Antibiotics; Burn; Pharmacokinetics; Subeschar tissue fluid; Vancomycin

Indexed keywords

AMIKACIN; CREATININE; VANCOMYCIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY SURFACE; BODY WEIGHT; BURN; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE SEVERITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RETENTION; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HALF LIFE TIME; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; OPEN STUDY; SINGLE DRUG DOSE; SUBESCHAR TISSUE FLUID; TISSUE WATER;

ADOLESCENT; ADULT; AMIKACIN; ANTI-BACTERIAL AGENTS; BURNS; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; VANCOMYCIN; YOUNG ADULT;

EID: 58149139252     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2008.05.016     Document Type: Article

References (17)

1. Bjerknes R., Vindenes H., and Laerum O.D. Altered neutrophil functions in patients with large burns. Blood Cells 16 (1990) 127-141
2. Mileski W., Borgstrom D., Lightfoot E., Rothlein R., Faanes R., Lipsky P., et al. Inhibition of leukocyte-endothelial adherence following thermal injury. J. Surg. Res. 52 (1992) 334-339
3. Nguyen T.T., Gilpin D.A., Meyer N.A., and Herndon D.N. Current treatment of severely burned patients. Ann. Surg. 223 (1996) 14-25
4. Bonate P.L. Pathophysiology and pharmacokinetics following burn injury. Clin. Pharmacokinet. 18 (1990) 118-130
5. Weinbren M.J. Pharmacokinetics of antibiotics in burn patients. J. Antimicrob. Chemother. 44 (1999) 319-327
6. Zaske D.E., Sawchuk R.J., and Strate R.G. The necessity of increased doses of amikacin in burn patients. Surgery 84 (1978) 603-608
7. Garrelts J.C., and Peterie J.D. Altered vancomycin dose versus serum concentration relationship in burn patients. Clin. Pharmacol. Ther. 44 (1988) 9-13
8. Rybak M.J., Albrecht L.M., Berman J.R., Warbasse L.H., and Svensson C.K. Vancomycin pharmacokinetics in burn patients and intravenous drug abusers. Antimicrob. Agents Chemother. 34 (1990) 792-795
9. Arturson G., and Jonsson C.E. Transcapillary transport after thermal injury. Scand. J. Plast. Surg. 13 (1979) 29-38
10. Heggers J.P., Ko F., Robson M.C., Heggers R., and Craft K.E. Evaluation of burn blister fluid. Plast. Reconstr. Surg. 65 (1980) 798-804
11. Tang Y.W. The effect of burn subeschar tissue fluid on skeletal muscle and hepatic amino acid uptake in an experimental system in vitro. Burns 25 (1999) 137-144
12. McManus W.F., Mason A.D., and Pruitt B.A. Subeschar antibiotic infusion in treatment of burn wound infection. J. Trauma 20 (1980) 1021-1023
13. Polk R.E., Mayhall C.G., Smith J., Hall G., Kline B.J., Swensson E., et al. Gentamicin and tobramycin penetration into burn eschar. Pharmacokinetics and microbiological effects. Arch. Surg. 118 3 (1983) 295-302
14. Polard E., Le Bouquin V., Le Corre P., Kerebel C., Trout H., Feuillu A., et al. Non-steady state and steady state PKs bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients. Ther. Drug Monit. 21 4 (1999) 395-403
15. Chen H.Y., and He W. The pharmacokinetics study of amikacin in old patients with respiratory system infections. China Pharm. 15 1 (2004) 39-40
16. Xu X.L., Fan X., Sun Y.G., and Zhang J.F. In vitro antibacterial activity of combined antimicrobial agents against methicillin-resistant Staphylococcus aureus. Chin. J. Antibiot. 29 (2004) 660-661
17. Hu B.J., Chen X.H., and Ni C.M. The evaluation and the result of 12 antibiotics sensitive to nosocomial infection bacteria. Chin. J. Nosocomial. 9 (1999) 118-120